Legal Representation
Attorney
Gregory F. Buhyoff
USPTO Deadlines
Application History
8 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 6, 2020 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Jan 6, 2020 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Jun 21, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 21, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 21, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 19, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 25, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 12, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Cell culture reagents for scientific and research use; Cells for scientific, laboratory or medical research; Reagents for scientific or medical research use; Assays and reagents for use in genetic research; Diagnostic reagents for scientific use
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
Cells for medical or clinical use; Pharmaceutical preparations in the nature of genetically modified therapeutic pharmaceuticals for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological, hematologic and viral diseases and disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; Pharmaceutical preparations in the nature of genetically modified therapeutic pharmaceuticals, namely, antifungal preparations, dermatological preparations, smoking cessation preparations and tissue repair preparations in the nature of biological tissue grafts; Diagnostic reagents for medicinal use
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Medical and scientific research in the field of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; Medical and scientific research information in the field of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; Pharmaceutical research and development; Pharmaceutical research services; Providing medical and scientific research information in the fields of pharmaceuticals and genetics
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
001
005
042